Business UpdateMay 28, 2026, 05:02 PM
Pelthos CEO to Present at Jefferies Global Healthcare Conference
AI Summary
Pelthos Therapeutics Inc. announced that its CEO, Scott Plesha, will present at the Jefferies Global Healthcare Conference on June 4, 2026, at 11:05 am ET in New York. He will also engage in one-on-one investor meetings. Pelthos is a biopharmaceutical company focused on cutaneous infectious disease products, with ZELSUVMI as its lead product for molluscum contagiosum, and other products like XEPI and XEGLYZE in its portfolio.
Key Highlights
- Pelthos Therapeutics CEO Scott Plesha will present at the Jefferies Global Healthcare Conference.
- The presentation is scheduled for June 4, 2026, at 11:05 am ET in New York.
- CEO Plesha will also participate in one-on-one investor meetings.
- Investors interested in meetings should contact their Jefferies representative.
- Pelthos's lead product is ZELSUVMI (berdazimer) topical gel for molluscum contagiosum.
- The company's portfolio includes XEPI Cream for impetigo and XEGLYZE for head lice.
Price Impact
More from PTHS